RecallDepth
Class II Ongoing

Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals, Pennington, NJ 08534. NDC 68382-110-06

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
October 23, 2025
Posted
November 26, 2025
Recall Number
D-0159-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
36,624 bottles
Firm Location
Pennington, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: M313934, M313935, M315615, Exp. Date Nov 2025; M316809 , Exp. Date Dec-25; M405765, M405763, M405764, Exp. Date Apr-26; M414999, M414241, M414307, M414305, Exp. Date Oct-26

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls